| 65 -- Consolidated Vaccines For Children |
| Program Summary |
 |
| Title: |
65 -- Consolidated Vaccines For Children |
| GovCB Opps ID : |
ADP11702179960000259 |
| Document Type: |
Modification to a Previous Notice |
| Solicitation No.: |
2007-N-09211 |
| Source: |
http://www1.fbo.gov/spg/HHS/CDCP/PGOA/2007%2DN%2D09211/Modification%2001.html |
Place of
Performance: |
Address: Contractor's place of performance Postal Code: 30341 Country: UNITED STATES
|
Posted Date:
|
Jan 31, 2007 |
| Last Update: |
Jan 31, 2007 |
| Due Date: |
Feb 22, 2007 |
|
| Description |
|
-
Response date changed to February 22, 2007:
The Centers for Disease Control and Prevention (CDC) is soliciting proposals for the award of multiple indefinite delivery, indefinite quantity contracts for the purchase of childhood vaccines included under the Vaccines for Children (VFC) program, pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93). CDC anticipates the award of one consolidated contract for each vaccine manufacturer to include all vaccines required by the VFC program, which the manufacturer produces. The applicable VFC vaccines are: Diphtheria and Tetanus Toxoid with Acellular Pertussis (DTaP), Diphtheria and Tetanus Toxoids with Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), and Poliovirus Vaccine Combined (DTaP/Hep B/IPV), Diphtheria and Tetanus Toxoids with Acellular Pertussis combined with Haemophilus Influenza Type b (DTaP/Hib), Enhanced Inactivated Polio (E-IPV), Hepatitis A (Pediatric), Hepatitis A & B Combination (for Age 18), Hepatitis B (Pediatric/Adolescent), Hepatitis B - 2-dose Regimen (Adolescents 11-15 only), Hepatitis B combined with Haemophilus Influenza Type b (Hep B/Hib), Haemophilus Influenza Type b (Hib), Human Papillomavirus Vaccine (HPV) types 6,11,16 and18 recombinant, Meningococcal Conjugate Vaccine (MCV4), Measles, Mumps, and Rubella Vaccine (MMR), Measles, Mumps, Rubella and Varicella (MMR-V), Pneumococcal Conjugate (7 Valent), Rotavirus, Tetanus and Diphtheria Toxoid (Td), Tetanus Toxoid, Reduced Diphtheria Toxoid with Acellular Pertussis Adsorbed (Tdap), and Varicella. Maximum estimated quantities, minimum order sizes, shelf life requirements and applicable price restrictions will be listed in the solicitation. Vaccines shall be shipped F.O.B. Destination to the 50 states and U.S. territories. Contracts shall be for a twelve month period beginning on or about 04/01/2007. Offerors must provide evidence of a current FDA establishment license and evidence of current FDA product licenses for all proposed products and must meet the definition of a manufacturer as stipulated by OBRA '93. Solicitation 2007-N-09211 will be posted online www.fedbizopps.gov on or about 01/23/2007. Hard copies of the solicitation will not be available. Contact Cherie Katin at 770-488-2652 or email: chk5@cdc.gov with any questions.
|
|
